Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Jacobio Pharma Presents Data of Glecirasib in Patients with Pancreatic Cancer and Other Solid Tumors at the 2024 ASCO GI 2024-01-20 06:30
CARsgen's Presents Updated Research Results on CT041 at 2024 ASCO GI Meeting 2024-01-19 21:50
Harbour BioMed Announces Positive Profit Alert 2024-01-19 12:52
FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN US 2024-01-18 10:31
Olverembatinib Included in Newest Guidelines on Chronic Myeloid Leukemia (CML) Management from the National Comprehensive Cancer Network (NCCN) 2024-01-17 12:10
Chipscreen NewWay: First Patient Dosed in Phase 1 Trial of the Bispecific Antibody NWY001, a Next-generation Tumor Immunotherapy in Patients with Advanced Solid Tumors 2024-01-16 17:00
CARsgen's CT011 achieves IND clearance from the NMPA for the GPC3-positive stage Ⅲa hepatocellular carcinoma at high risk of recurrence after surgical resection 2024-01-15 21:50
Positive Outcome from a Phase Ib Study in Australia Treating Patients with Androgenic Alopecia 2024-01-15 08:08
Qilian International Holding Group Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule 2024-01-12 20:30
ClinChoice Acquires CSI, Expanding its Global Footprint into Southeast Asia 2024-01-12 11:00
GenFleet Therapeutics Announces GFH009 Granted with FDA Fast Track, Orphan Drug Designations for Treating R/R Peripheral T-cell Lymphomas and Acute Myeloid Leukemia 2024-01-11 19:00
CEO of Kelun-Biotech Dr. Micheal Ge delivered a presentation on The 42nd JPM Annual Healthcare Conference 2024-01-11 17:55
SyntheticGestalt and Enamine to Collaborate on the Creation of AI-Based Model to Facilitate Drug Discovery 2024-01-11 16:00
Ascentage Pharma Presented at 42nd Annual J.P. Morgan Healthcare Conference 2024-01-11 11:53
New Chinese medicine drug developed by HKBU for myofibrillar myopathy granted orphan drug designation by FDA 2024-01-10 16:50
LOTTE BIOLOGICS Announces Songdo Bio Plant Development Plan at JPM Healthcare Conference 2024 2024-01-10 08:55
Enhancing Leadership in Gynecology, Asieris Pharmaceuticals Appoints Sophia Cao to Lead the Newly-Established Women's Health Business Unit, Accelerating Strategic Expansion 2024-01-09 12:25
Abbisko Therapeutic announces that EMA has granted orphan drug designation for its CSF-1R inhibitor Pimicotinib (ABSK021) 2024-01-09 08:30
Akeso to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Share Its Corporate & Innovative Clinical Development Roadmap 2024-01-08 21:38
Biosion's Partner OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992 (TROP2 ADC) 2024-01-08 19:35
1 27 28 29 30 31 166